Testo completo - Associazione Italiana di Aritmologia e ...

Indicazioni all’impianto di pacemaker nella malattia del nodo del seno e nella fibrillazione atriale
28) Paladino W, Bahu M, Knight BP, et al.: Failure of single - and
multisite high-frequency atrial pacing to terminate atrial fibrillation.
Am J Cardiol 1997;80:226-7.
29) Israel CW, Ehrlich JR, Gronefeld G et al.: Prevalence, characteristics
and clinical implications of regular atrial tachyarrhythmias
in patients with atrial fibrillation: insights from a
study using a new implantable device. J Am Coll Cardiol
2001;38:355–363.
30) Ricci R, Pignalberi C, Disertori M, et al: Antitachycardia pacing
therapy to treat spontaneous atrial tachyarrhythmias: the
7250 Dual Defibrillator Italian Registry. Eur Heart J 2001;3(Suppl.
P):P25-P32.
31) Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE: for
the Worldwide Jewel AF-Only Investigators. Clinical experience
with a dual chamber implantable cardioverter defibrillator to
treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol
2001;12:1247-1253.
32) Boriani G, Padeletti L, Santini M, et al.: Predictors of atrial
antitachycardia pacing efficacy in patients affected by bradytachy
form of sick sinus sindrome and implanted with a DDDRP
device. J Cardiovasc Electrophysiol 2005;16:714-23.
33) Padeletti L, Purerfellner H, Adler S, et al.: Atrial septal lead
placement and atrial pacing algorithms for prevention of paroxysmal
atrial fibrillation: ASPECT Study results. Pacing Clin
Electrophysiol 2002;24:687.
34) Lee MA, Weachter R, Pollak S et al.: The effect of atrial pacing
therapies on atrial tachyarrhythmia burden and frequency:
results of a randomized trial in patients with bradycardia and
atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.
35) Gillis AM, Koehler J, Morck M et al.: High atrial antitachycardia
pacing therapy efficacy is associated with a reduction in
atrial tachyarrhythmia burden in a subset of patients with sinus
node dysfunction and paroxysmal atrial fibrillation. Heart
Rhythm 2005;2:791-796.
36) Wilkoff BL, Cook JR, Epstein AE, et al.: The DAVID Trial
Investigators: Dual chamber pacing or ventricular bacup pacing
in patients with an implantable defibrillator. The Dual Chamber
17
and VVI Implantable Defibrillator (DAVID) Trial. JAMA
2002;288:3115-23.
37) Andersen HR, Nielsen JC, Bloch Thomsen PE, et al.:
Atrioventricular conduction during long-term follow-up of
patients with sick sinus syndrome. Circulation 1998;98:1315-
1321.
38) Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR:
Programming a fixed long atrioventricular delay is not effective
in preventing ventricular pacing in patients with sick sinus syndrome.
Europace 1999;1:113-20.
39) Mayumi H, Kohno H, Yasui H, Kawachi Y, Tokunaga K: Use
of automatic mode change between DDD and AAI to facilitate
native atrioventricular conduction in patients with sick sinus
syndrome or transient atrioventricular block. Pacing Clin
Electrophysiol 1996;19:1740-1747.
40) Melzer C, Sowelam S, Sheldon TJ, et al.: Reduction of right
ventricular pacing in patients with sinus node dysfunction using
an enhanced search AV algorithm. Pacing Clin Electrophysiol
2005;28:521-7.
41) Sweeney M, Shea J, Fox V, et al.: Randomized pilot study of a
new atrial-based minimal ventricular pacing mode in dual-chamber
implantable cardioverter-defibrillators. Heart Rhythm
2004;1:160-7.
42) Wood MA, Brown-Mahoney C, Kay n, et al.: Clinical outcomes
after ablation and pacing therapy for atrial fibrillation. A meta
analysis. Circulation 2000;101:1138-1144.
43) Geelen P, Brugada J Andries E, Brugada P. Ventricula fibrillation
and sudden death after radiofrequency catheter ablation of
the atrioventricular junction. PACE 1997;20:343-348.
44) Jensen SJ, Bergfeldt L, Rosenqvist M: Long-term follow-up of
patients treated by radiofrequency ablation of the atrioventricular
junction. PACE 1995;1:1609-1614.
45) Simantirakis EN, Vardakis KE, Kochiadakis GE, et al.: Left ventricular
mechanics during right ventricular apical or left ventricular-based
pacing in patients with chronic atrial fibrillation
after atrio-ventricular junction ablation. J Am Coll Cardiol
2004;43:1013-8.